Skip to main content
Top
Published in: Journal of Gastroenterology 6/2012

Open Access 01-06-2012 | Original Article—Liver, Pancreas, and Biliary Tract

Algorithm to determine the outcome of patients with acute liver failure: a data-mining analysis using decision trees

Authors: Nobuaki Nakayama, Makoto Oketani, Yoshihiro Kawamura, Mie Inao, Sumiko Nagoshi, Kenji Fujiwara, Hirohito Tsubouchi, Satoshi Mochida

Published in: Journal of Gastroenterology | Issue 6/2012

Login to get access

Abstract

Background

We established algorithms to predict the prognosis of acute liver failure (ALF) patients through a data-mining analysis, in order to improve the indication criteria for liver transplantation.

Methods

The subjects were 1,022 ALF patients seen between 1998 and 2007 and enrolled in a nationwide survey. Patients older than 65 years, and those who had undergone liver transplantation and received blood products before the onset of hepatic encephalopathy were excluded. Two data sets were used: patients seen between 1998 and 2003 (n=698), whose data were used for the formation of the algorithm, and those seen between 2004 and 2007 (n=324), whose data were used for the validation of the algorithm. Data on a total of 73 items, at the onset of encephalopathy and 5 days later, were collected from 371 of the 698 patients seen between 1998 and 2003, and their outcome was analyzed to establish decision trees. The obtained algorithm was validated using the data of 160 of the 324 patients seen between 2004 and 2007.

Results

The outcome of the patients at the onset of encephalopathy was predicted through 5 items, and the patients were classified into 6 categories with mortality rates between 23% and89%. When the prognosis of the patients in the categories with mortality rates greater than 50% was predicted as “death”, the accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the algorithm were 79, 78, 81, 83, and 75%, respectively. Similar high values were obtained when the algorithm was employed in the patients for validation. The outcome of the patients 5 days after the onset of encephalopathy was predicted through 7 items, and a similar high accuracy was found for both sets of patients.

Conclusions

Novel algorithms for predicting the outcome of ALF patients may be useful to determine the indication for liver transplantation.
Literature
1.
go back to reference Mochida S, Takikawa Y, Nakayama N, Oketani M, Naiki T, Yamagishi Y, et al. Diagnostic criteria of acute liver failure: a report by the Intractable Hepato-Biliary Diseases Study Group of Japan. Hepatol Res. 2011;41:805–12.PubMedCrossRef Mochida S, Takikawa Y, Nakayama N, Oketani M, Naiki T, Yamagishi Y, et al. Diagnostic criteria of acute liver failure: a report by the Intractable Hepato-Biliary Diseases Study Group of Japan. Hepatol Res. 2011;41:805–12.PubMedCrossRef
2.
go back to reference Inuyama Symposium Kiroku Kanko-Kai. The proceedings of the 12th Inuyama symposium. Hepatitis type A and fulminant hepatitis. Chugai Igaku-sha, Tokyo. 1982 (in Japanese). Inuyama Symposium Kiroku Kanko-Kai. The proceedings of the 12th Inuyama symposium. Hepatitis type A and fulminant hepatitis. Chugai Igaku-sha, Tokyo. 1982 (in Japanese).
3.
go back to reference Mochida S, Fujiwara K. Symposium on clinical aspects in hepatitis virus infection. 2. Recent advances in acute and fulminant hepatitis in Japan. Intern Med. 2001;40:175–7.PubMedCrossRef Mochida S, Fujiwara K. Symposium on clinical aspects in hepatitis virus infection. 2. Recent advances in acute and fulminant hepatitis in Japan. Intern Med. 2001;40:175–7.PubMedCrossRef
4.
go back to reference Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G, et al. Fulminant hepatitis and late onset hepatic failure in Japan: Summary of 698 patients between 1998 and 2003 analyzed in annual nationwide survey. Hepatol Res. 2008;38:646–57.PubMedCrossRef Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G, et al. Fulminant hepatitis and late onset hepatic failure in Japan: Summary of 698 patients between 1998 and 2003 analyzed in annual nationwide survey. Hepatol Res. 2008;38:646–57.PubMedCrossRef
5.
go back to reference Sugihara J, Naito T, Ishiki Y, Murakami N, Naiki T, Koshino Y, et al. A multicenter study on the prognosis and indication of liver transplantation for fulminant hepatitis in Japan: details of decision of the guideline for liver transplantation in Japanese Acute Hepatic Failure Study Group (1996). Acta Hepatol Japonica. 2001;42:543–57 (in Japanese). Sugihara J, Naito T, Ishiki Y, Murakami N, Naiki T, Koshino Y, et al. A multicenter study on the prognosis and indication of liver transplantation for fulminant hepatitis in Japan: details of decision of the guideline for liver transplantation in Japanese Acute Hepatic Failure Study Group (1996). Acta Hepatol Japonica. 2001;42:543–57 (in Japanese).
6.
go back to reference Mochida S, Nakayama N, Matsui A, Nagoshi S, Fujiwara K. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. Hepatol Res. 2008;38:970–9.PubMedCrossRef Mochida S, Nakayama N, Matsui A, Nagoshi S, Fujiwara K. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. Hepatol Res. 2008;38:970–9.PubMedCrossRef
7.
go back to reference Nakayama N, Oketani M, Kawamura Y, Inao M, Nagoshi S, Fujiwara K, et al. Novel classification of acute liver failure through clustering using a self-organizing map: usefulness for prediction of the outcome. J Gastroenterol. 2011;46:1127–35.PubMedCrossRef Nakayama N, Oketani M, Kawamura Y, Inao M, Nagoshi S, Fujiwara K, et al. Novel classification of acute liver failure through clustering using a self-organizing map: usefulness for prediction of the outcome. J Gastroenterol. 2011;46:1127–35.PubMedCrossRef
9.
go back to reference Talbi ML, Charef A. PVC discrimination using the QRS power spectrum and self-organizing maps. Comput Methods Programs Biomed. 2009;94:223–31.PubMedCrossRef Talbi ML, Charef A. PVC discrimination using the QRS power spectrum and self-organizing maps. Comput Methods Programs Biomed. 2009;94:223–31.PubMedCrossRef
10.
go back to reference Basara HG, Yuan M. Community health assessment using self-organizing maps and geographic information systems. Int J Health Geogr. 2008;30(7):67.CrossRef Basara HG, Yuan M. Community health assessment using self-organizing maps and geographic information systems. Int J Health Geogr. 2008;30(7):67.CrossRef
11.
go back to reference Tsunedomi R, Iizuka N, Hamamoto Y, Uchimura S, Miyamoto T, Tamesa T, et al. Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma. Int J Oncol. 2005;27:661–7.PubMed Tsunedomi R, Iizuka N, Hamamoto Y, Uchimura S, Miyamoto T, Tamesa T, et al. Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma. Int J Oncol. 2005;27:661–7.PubMed
12.
go back to reference Haydon GH, Hiltunen Y, Lucey MR, Collett D, Gunson B, Murphy N, et al. Self-organizing maps can determine outcome and match recipients and donors at orthotopic liver transplantation. Transplantation. 2005;79:213–8.PubMedCrossRef Haydon GH, Hiltunen Y, Lucey MR, Collett D, Gunson B, Murphy N, et al. Self-organizing maps can determine outcome and match recipients and donors at orthotopic liver transplantation. Transplantation. 2005;79:213–8.PubMedCrossRef
13.
go back to reference Omori K, Terai S, Ishikawa T, Aoyama K, Sakaida I, Nishina H, et al. Molecular signature associated with plasticity of bone marrow cell under persistent liver damage by self-organizing-map-based gene expression. FEBS Lett. 2004;578:10–20.PubMedCrossRef Omori K, Terai S, Ishikawa T, Aoyama K, Sakaida I, Nishina H, et al. Molecular signature associated with plasticity of bone marrow cell under persistent liver damage by self-organizing-map-based gene expression. FEBS Lett. 2004;578:10–20.PubMedCrossRef
14.
go back to reference Gebbinck MS, Verhoeven JT, Thijssen JM, Schouten TE. Application of neural networks for the classification of diffuse liver disease by quantitative echography. Ultrason Imaging. 1993;15:205–17.PubMedCrossRef Gebbinck MS, Verhoeven JT, Thijssen JM, Schouten TE. Application of neural networks for the classification of diffuse liver disease by quantitative echography. Ultrason Imaging. 1993;15:205–17.PubMedCrossRef
15.
go back to reference Takasaki S, Kawamura Y, Konagaya A. Selecting effective siRNA sequences based on the self-organizing map and statistical techniques. Comput Biol Chem. 2006;30:169–78.PubMedCrossRef Takasaki S, Kawamura Y, Konagaya A. Selecting effective siRNA sequences based on the self-organizing map and statistical techniques. Comput Biol Chem. 2006;30:169–78.PubMedCrossRef
16.
go back to reference Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 2006;34:625–31.PubMed Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 2006;34:625–31.PubMed
17.
go back to reference Bellazzi R, Zupan B. Predictive data mining in clinical medicine: current issues and guidelines. Int J Med Inform. 2008;77:81–97.PubMedCrossRef Bellazzi R, Zupan B. Predictive data mining in clinical medicine: current issues and guidelines. Int J Med Inform. 2008;77:81–97.PubMedCrossRef
18.
go back to reference Luk JM, Lam BY, Lee NP, Ho DW, Sham PC, Chen L, et al. Artificial neural networks and decision tree model analysis of liver cancer proteomes. Biochem Biophys Res Commun. 2007;361:68–73.PubMedCrossRef Luk JM, Lam BY, Lee NP, Ho DW, Sham PC, Chen L, et al. Artificial neural networks and decision tree model analysis of liver cancer proteomes. Biochem Biophys Res Commun. 2007;361:68–73.PubMedCrossRef
19.
go back to reference Kawaguchi T, Kakuma T, Yatsuhashi H, Watanabe H, Saitsu H, Nakao K, et al. Data mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma. Hepatol Res. 2011;41:564–71.PubMedCrossRef Kawaguchi T, Kakuma T, Yatsuhashi H, Watanabe H, Saitsu H, Nakao K, et al. Data mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma. Hepatol Res. 2011;41:564–71.PubMedCrossRef
20.
go back to reference Kurosaki M, Hiramatsu N, Sakamoto M, Suzuki Y, Iwasaki M, Tamori A, et al. Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C. J Hepatol. 2011 (Epub ahead of print). Kurosaki M, Hiramatsu N, Sakamoto M, Suzuki Y, Iwasaki M, Tamori A, et al. Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C. J Hepatol. 2011 (Epub ahead of print).
21.
go back to reference Kurosaki M, Sakamoto N, Iwasaki M, Sakamoto M, Suzuki Y, Hiramatsu N, et al. Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis. J Gastroenterol. 2011;46:401–9.PubMedCrossRef Kurosaki M, Sakamoto N, Iwasaki M, Sakamoto M, Suzuki Y, Hiramatsu N, et al. Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis. J Gastroenterol. 2011;46:401–9.PubMedCrossRef
22.
go back to reference Kurosaki M, Sakamoto N, Iwasaki M, Sakamoto M, Suzuki Y, Hiramatsu N, et al. Sequences in the interferon sensitivity-determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin: data mining analysis. J Med Virol. 2011;83:445–52.PubMedCrossRef Kurosaki M, Sakamoto N, Iwasaki M, Sakamoto M, Suzuki Y, Hiramatsu N, et al. Sequences in the interferon sensitivity-determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin: data mining analysis. J Med Virol. 2011;83:445–52.PubMedCrossRef
23.
go back to reference Yoshiba M, Inoue K, Sekiyama K, Koh I. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs. 1996;20:1169–72.PubMedCrossRef Yoshiba M, Inoue K, Sekiyama K, Koh I. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs. 1996;20:1169–72.PubMedCrossRef
24.
go back to reference Sekido H, Matsuo K, Takeda K, Ueda M, Morioka D, Kubota T, et al. Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure. Transplant Proc. 2004;36:2355–6.PubMedCrossRef Sekido H, Matsuo K, Takeda K, Ueda M, Morioka D, Kubota T, et al. Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure. Transplant Proc. 2004;36:2355–6.PubMedCrossRef
25.
go back to reference Inoue K, Watanabe T, Maruoka N, Kuroki Y, Takahashi H, Yoshiba M. Japanese-style intensive medical care improves prognosis for acute liver failure and the perioperative management of liver transplantation. Transplant Proc. 2010;42:4109–12.PubMedCrossRef Inoue K, Watanabe T, Maruoka N, Kuroki Y, Takahashi H, Yoshiba M. Japanese-style intensive medical care improves prognosis for acute liver failure and the perioperative management of liver transplantation. Transplant Proc. 2010;42:4109–12.PubMedCrossRef
26.
go back to reference Kubota T, Sekido H, Takeda K, Morioka D, Tanaka K, Endo I, et al. Acute hepatic failure with deep hepatic coma treated successfully by high-flow continuous hemodiafiltration and living-donor liver transplantation: a case report. Transplant Proc. 2003;35:394–6.PubMedCrossRef Kubota T, Sekido H, Takeda K, Morioka D, Tanaka K, Endo I, et al. Acute hepatic failure with deep hepatic coma treated successfully by high-flow continuous hemodiafiltration and living-donor liver transplantation: a case report. Transplant Proc. 2003;35:394–6.PubMedCrossRef
27.
go back to reference Inoue K, Kourin A, Watanabe T, Yamada M, Yasuda H, Yoshiba M. Plasma exchange in combination with online-hemodiafiltration as a promising method for purifying the blood of fulminant hepatitis patients. Hepatol Res. 2008;38:S46–51.PubMedCrossRef Inoue K, Kourin A, Watanabe T, Yamada M, Yasuda H, Yoshiba M. Plasma exchange in combination with online-hemodiafiltration as a promising method for purifying the blood of fulminant hepatitis patients. Hepatol Res. 2008;38:S46–51.PubMedCrossRef
28.
go back to reference O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.PubMed O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.PubMed
Metadata
Title
Algorithm to determine the outcome of patients with acute liver failure: a data-mining analysis using decision trees
Authors
Nobuaki Nakayama
Makoto Oketani
Yoshihiro Kawamura
Mie Inao
Sumiko Nagoshi
Kenji Fujiwara
Hirohito Tsubouchi
Satoshi Mochida
Publication date
01-06-2012
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 6/2012
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-012-0529-8

Other articles of this Issue 6/2012

Journal of Gastroenterology 6/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.